chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first dose of the Pfizer vaccine was taken on March 15th at 8:30. Within a week I started feeling weak joints, headaches followed by a sharp pain on the occipital lobe. I started my period for the second time that month, which was odd because it never happened to me before. I went to work that week, but by Friday (March 30th) I was not able to handle the pain so after work I went to the doctor and they took blood to see if there was anything going on. The result came back the following day and everything was normal. I was given medicine (muscle relaxers) for the occipital pain, but it was not enough. At that time I was not sure what was the cause of it, I thought it was a bad flu, but I didn't come to the conclusion that it was because of the vaccine, because a week had passed by, so I thought it was impossible. The doctor asked for me to take an X-Ray for the occipital pain, so I did (March 30th) and it resulted in everything being fine. She also recommended for me to get an abdominal ultrasound to see if my uterus was fine due to the second period. I currently took the second Pfizer dose in the same location, but this time around I felt all of these symptoms within 3 hours of the vaccination. I started feeling lightheaded and dazed, my joints started feeling weak, my mouth and tongue started feeling sensitive (fever blisters and sensitive to anything that is acidic, spicy, etc).  I have not visited the doctor this time around because the pain is tolerable. I have noticed in increase of joint pain as the days go by.
Became pregnant 1st & 3rd vax. Postive test on 3/22. Probable miscarriage on 3/26.
Temperature of 99/highest temperature is 101; Running fever; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE (Temperature of 99/highest temperature is 101) and PYREXIA (Running fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B212A and 025B21A) for COVID-19 vaccination.     Concomitant products included ALBUTEROL [SALBUTAMOL], BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), LEVOCETIRIZINE, CYCLOBENZAPRINE, ATORVASTATIN, MONTELUKAST, MELOXICAM and DOCUSATE SODIUM (STOOL SOFTENER) for an unknown indication.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced BODY TEMPERATURE (Temperature of 99/highest temperature is 101) and PYREXIA (Running fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and CAFFEINE, PARACETAMOL (EXCEDRIN [CAFFEINE;PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, BODY TEMPERATURE (Temperature of 99/highest temperature is 101) and PYREXIA (Running fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (Inconclusive) Inconclusive and 99 (Inconclusive) Inconclusive.         After second dose, patient started running fever and the temperature was 99. Then the temperature increased to 101.   This case was linked to MOD-2021-110226 (Patient Link).
Had flu shot Thursday before Thanksgiving. Next day mild fever. Following day had severe joint pain, limbs, back, which has persisted. Called HD today. Patient called health department. Front desk called me. This is all I know not his provider though I advised him to call his doctor today.
Had vaccine on L arm on Mon.  Mon afternoon stiff L arm and hurt.  Tue evening felt a lot of pain to lymph note under left arm pain.
She said she is not pregnant and her menstrual cycle is a week late; This is spontaneous report from a contactable consumer (patient). This consumer reported for herself that a 24-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, NDC: Unknown, batch/lot number: EW0173; expiry date: 31Aug2021), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medication history and concomitant medications were not reported. The patient informed that she received her first dose of the Pfizer covid vaccine and she did not get her period. She said she was not pregnant, and her menstrual cycle was a week late. Caller wanted to know if that has been reported as a possible side effect of the vaccine. The The patient reported menstruation after she got the Pfizer Covid Vaccine. She was curious about possible symptoms, if menstruation was considered irregular or as like a symptom from the Pfizer Covid Vaccine. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected
ANGIOEDEMA, INIT 2/2/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Rec'd the shot at 2:45 on 4/2. By 5:00 PM, my left arm was swelling with pain. By 7:00 PM, the pain had spread to my left lymph node, shoulder, left breast, left torso, left hip, left buttock and left outer thigh. I became fatigued and tried to sleep. The pain in those areas intensified to a 10 (on a scale from 1-10) making it impossible to sleep or even move correctly. I was nauseous from the pain which was worse than any pain I have ever felt in my entire life. I developed a severe headache and dry heaves. I could not eat. The next day (4/3) I was able to sleep and I slept all day, rising only to use the toilet and sip water. I had a fever of 100.7. I continued sleeping the rest of the day. The pain continued but was more like aches. Severe headache remained until 3:00 on 4/4. When I awakened on 4/4, I noticed a light rash on my left side, mainly on my neck and chest. My left eye was bloodshot. The headache remained, but I was able to rise and function with minor pain and joint aches. 4/5 I am better.
Information has been received from a pharmacist referring to a 56 year old female patient with fibromyalgia, lumbosacral disk degeneration and no drug allergies. On 30-SEP-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # K009809, expiration date 16-MAY-2015, intramuscular; dose not reported). Concomitant therapies included AFLURIA which was vaccinated in the other arm on the same day, potassium, CYMBALTA, PERCOCET, FIORICET, LUNESTA, VALIUM, FLEXERIL, LASIX, PRILOSEC, ropinirole, LIPITOR, LYRICA, pilocarpine and ZESTRIL. Later the same day (30-SEP-2014) the patient began to have "throbbing pain down through the muscle and bone" at the injection site of PNEUMOVAX 23. The patient sought medical attention by calling the pharmacist. No treatment was given for the event and no lab diagnostics studies were performed. The outcome of the event was reported as not recovered. Additional information has been requested.
p/ pt recv vax in 9/97 pt in 8/98 devel many chickenpox lesions, more info requested
I received the Covid-19 Vaccine 04/02/2022. Woke up June 30,2022 with a sore throat and  fever of 99.4 and took a Covid-19 test and was positive. I called my doctor office and was suggested to take Paxlovid. I took the medication about 4:30 that same day and finished 07/05/2022.
Breaking out in hives in a circle around the area that I received the shot. Arm very red and itchy
Amenorrhea, LMP: 4/25/21, usually cycle varies between 28-30 days and is very regular, experiencing minimal occasional cramping that assimilate to menstrual  cramps without any spotting or bleeding still as of today 06/01/21
battling nerve issues; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUS SYSTEM DISORDER (battling nerve issues) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVOUS SYSTEM DISORDER (battling nerve issues). The patient was treated with OXYCODONE HYDROCHLORIDE (OXYCONTIN) for Nervous system disorder, at an unspecified dose and frequency. At the time of the report, NERVOUS SYSTEM DISORDER (battling nerve issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was due for the second shot on 14MAR2021. Treatment medication include steroids for battling nerve issues. No concomitant medications were reported.   Reporter did not allow further contact
Physician diagnosed chickenpox today 1/8/04 Rash onset 01/07/2004 Rash noted on trunk and some on extremities.  Vaccine Failure
Per mom, she states child awakened with swollen L thigh this AM. Assessed as 8 X 4cm red, slightly firm area, warm to tough. 4/24/06, per dad, recovered.
taken the shots still had it/suspected vaccination failure; had it at least three times; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: taken the shots still had it/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: had it at least three times). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 21-MAR-2023 The case  was received from the patient's friend via interactive digital media. The patient had taken the shots but still had shingles at least three times. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
p/vax pt devel fever & crying which lasted 2hr;pt was seen by MD 4/23/99;
Numbness right side of cheek and lip. Follow up: First office visit 10/27/04. Diagnosis: reaction to flu vaccine. No treatment given. Seen for FU 10/29/2004 and had improved.
Dizzy and off balance for 2 days, 1st day worst than 2nd day.
Case number PHEH2013US008348 is an initial spontaneous report received from a nurse on 10 Apr 2013. This report refers to an 18-year-old male patient. His medical history and concomitant medication was not reported. He was vaccinated with MENVEO (batch number: X12013 and expiry date: Oct 2014) at 0.5 ml intramuscularly on 19 Mar 2013. MENVEO vaccine was stored at 33-36F for 19 days and vaccine was not frozen. No adverse event was reported following this administration error.
Tinnitus developed shortly after COVID vaccine.  It has never diminished or gone away in over a year.
Still dealing with nerves damage; This case was reported by a consumer via interactive digital media and described the occurrence of nerve damage in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In September 2021, the patient received Shingles vaccine. On an unknown date, less than 4 months after receiving Shingles vaccine, the patient experienced nerve damage. On an unknown date, the outcome of the nerve damage was not recovered/not resolved.   It was unknown if the reporter considered the nerve damage to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's wife. The age at vaccination was not reported. The reporter stated, patient received vaccine when retured home from vacation and was still dealing till the time of reporting with nerve damage in patient's chest. The reporter did not consented to follow up.
redness; soreness; quite a bit or 2 to 3 drops of still wet, coagulated blood; This is a spontaneous report from a contactable consumer (patient) or other non HCP  A 65-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route of administration, on 02jun2021 as 2nd dose, single dose for COVID-19 immunization. The patient medical history included ITP (Idiopathic thrombocytopenic purpura). concomitant medications were not reported. On 03jun2021, 1 day after the vaccination, the patient experienced quite a bit or 2 to 3 drops of still wet, coagulated blood after removing bandage (after wiping it away, her arm wasn't actively bleeding), redness and soreness. She enquired regarding explaining the medical conditions including bleeding disorder or blood thinners to vaccination provider which was mentioned in the fact sheet. In response to her history of Idiopathic thrombocytopenic purpura she was informed that When vaccinating Persons with Increased Bleeding Risk, providers often avoid giving intramuscular injections or choose alternative routes because of the risk for hematoma formation after injections. The outcome of the events was unknown.  Information on the lot/batch number has been requested
We had tested allergic.  Medicine history: ZyrTEC Allergy 10MG Caps. When he attacks she papules all over her body sometimes making it hard to breathe.  We don't have any medicine so far unless she attacks; just keep away from allergic resources.
This spontaneous report as received from a physician refers to a 14 year old female patient with no pertinent medical history or no drug reactions/allergies. On 14-NOV-2013 the patient was vaccinated with the first dose of GARDASIL injection (dose, route, lot # and expiration date unknown) and a dose of FLUMIST (dose, route, manufacturer unknown). There was no concomitant medication. On 17-NOV-2013, 3 days later the patient developed a movement disorder similar to Tourette's Syndrome. Routine blood work was performed on an unknown date which came back normal. The patient possibly received her vaccinations from another doctor but the reporting physician was not sure. The patient had been to the emergency room and was given intravenous ATIVAN. The reporting physician had prescribed INTUNIV. The patient was not recovered from the event at the time of the report. The physician also mentioned that he saw on the internet (using Google) there were 12 school girls who received GARDASIL a couple of years ago and they then developed Tourette's Syndrome (captured in MARRS# 1401USA001712, 1401USA002947, 1401USA002941, 1401USA002942, 1401USA002943, 1401USA002944, 1401USA002945, 1401USA002946, 1401USA002939, 1401USA002938, 1401USA002937, 1401USA002940). He had no further information about these school girls or the name of the website where he saw this report. Additional information has been requested.
no adverse events occurred. vaccine was short dated upon arrival(less than 10 weeks left on exp when received at pharmacy) vaccine was given after exp set by mfg, but has been extended by manufacturer to include the date vaccine was given
27Mar96 pt recv 1 dose vax. 16Feb98 pt was "diagnosed w/full blown chickenpox".
Major swelling under left arm as of 11/6/2021.   Swelling at injection site moved to the front of the arm on 11/9/2021.  Swelling in neck on left side causing pain and off and on fever.   Unable to perform normal activities.  Went to PCP today and will begin warm, wet compresses to areas of swelling with twice daily anti-inflammatory medicine.  I have photos of the swelling.
Developed cellulitis in (L) shoulder following pneumococcal 23-valent treated Kw 7 days of dicloxacillin 500mg.
Immediately after injection was given patient had a 15 sec, unresponsive episode with upper extremity stiffness and slight jerky movements. Noted .5 cm bump on left forehead where he struck table top. BP 110/70 P. 70 c/o nausea - sml amt diaphoresis noted.
Patient got the chills and was nauseous several hours after receiving the vaccination. Patient reported vomiting and feeling very weak that evening but felt better the following day.
Patient reported 2 hours after receiving first dose of COVID-19 Pfizer vaccine she developed stabbing left sided chest pain, fatigue, swelling and pain at the site of injection in the left upper deltoid muscle.  This chest pain and fatigue persisted into the following week.  Patient was evaluated in our office on 11/11/21 w/ chest pain still present but slightly improved.  A chest X-ray and echocardiogram were ordered as well as blood work including troponin, CK levels.  Her echocardiogram was completely WNL, no structural cardiac abnormalities.  Blood work showed elevated CK at 831 U/L but otherwise WNL.  Chest X-ray showed two solitary nodules in the upper right chest along the clavicle.  At first these were thought to be skin level but upon further examination in office on 11/16/21 determined more likely to be pulmonary nodules.  Patient was referred to pulmonology at this time.  On 11/16/21 in the office the patient was complaining of worsening upper left chest and back pain as well as palpitations.  Still felt fatigued, tired and anxious, mostly about these adverse symptoms.  Repeat blood work was ordered including Quantiferon TB to investigate symptoms and pulmonary findings as well as repeat CK level and urine studies.  Patient denied any hx of sarcoidosis, lupus, TB exposure or other autoimmune respiratory syndromes.  Patient's CK had normalized to 76 U/L, other blood work and urine labs were WNL.  Patient reported chest pain and fatigue had been improving w/ rest, fluids and avoiding strenuous activity.  Patient was finally evaluated again in our office on 12/9/21 for a follow up.  She was seen and evaluated by cardiology, cleared by them for any concern of cardiac pathology causing her symptoms.  She also saw pulmonology who on repeat X-ray noted the pulmonary nodules had disappeared.  However, they did note mild right middle lobe atelectasis possibly related to a passing viral illness and/or underlying inflammatory process.  Current plans are to follow up w/ pulmonology for continued PFTs and monitoring.  At this time patient had reported her chest pain had greatly improved, denied any further fatigue, palpitations, other myalgias or dizziness.  We have currently referred the patient to an allergist for testing and recommendations regarding possible allergic reaction to COVID-19 vaccine and whether she can safely receive the 2nd dose in the future.  Currently planning to continue follow up w/ pulmonology and monitor symptoms going forward.  Multiple symptoms likely due to adverse reaction to Pfizer COVID-19 vaccination including acute muscle breakdown in the upper chest, inflammatory reactions causing acute chest pain, dizziness and fatigue with no serious cardiac pathology underlying based on current evaluations.
Throat constriction, difficulty swallowing, diff, 3:00-4:00PM, antacid. Fever/chills, shivering, 4:00-7:00PM, aspirin.
I developed hives 2 weeks after vaccine, which responded to antihistamine. 4 weeks later I developed hives that did not respond to antihistamines and required 21 days of steroids to resolve.
Inflammation, heat, itchiness, tenderness at injection site. 2in in diameter onset 1 week post injection
gastrointestinal pain, explosive diarrhea, stomach upset, stopped eating 4 days , couldn't swallow or ingest anything, I was gagging and couldn't keep anything down. low white blood cells.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 06-APR-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017. This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 136 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 40 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Addition information has been requested.
Information has been received from a healthcare worker (office manager) referring to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored doses of GARDASIL (lot # K010215, expiration date 05-MAY-2017; lot # L040459, expiration date 06-APR-2017; dose and route were unknown). No symptoms were reported. The vaccines were stored under 1 degree centigrade for 6 days in November 2015, 1 degree centigrade for 20 days in December 2015, 1 degree centigrade for 16 days in January 2016, 1 degree centigrade for 20 days in February 2016 (totally 62 days). No other excursions were involved. This is one of several reports received from the same reporter. Additional information has been requested.
Nausea, muscle aches, soreness, fever, chills, headache, fatigue, loss of appetite all remained for 3 days after vaccine. 4th day after still had headache and mild fever.
My arm was very sore the evening after I received the injection and the next day I had a raised red area  around the injection site (about 5 to 6 inches in diameter) and I had a fever and temp of 101 degrees. I also had aching in my legs. The second day after the injection, the arm  was not as sore and the redness had  gotten lighter. The fever was gone.
Began with a sharp pain on buttocks on the left side. Later noticed what might have been a bug bite. The next day had ache type pain in lower left quandrant on back. Then determined the "bite" was part of a rash. Diagnosed with shingles (mild to moderate)
worse than the swine flu; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date: unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The patient received the second dose of the vaccine and the side effects was reported as 'worse than the swine flu.' The nurse reported that the side effects lasted 24 hours. The outcome of the event was unknown.   Information about lot/batch number has been requested.
Menveo vaccine administered expired on 5/31/2022 so patient received an expired menveo.  Patient will come back in to have another dose administered.
inadvertently administered Kinrix to a 1 year 3 month old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-year-old female patient who received DTPa-IPV (Kinrix) (batch number 25ZH4, expiry date 27-OCT-2024) for prophylaxis.   On 03-JUL-2023, the patient received Kinrix (left arm). On 03-JUL-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: inadvertently administered Kinrix to a 1 year 3 month old patient). The outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 3-JUL-2023 License practical nurse called to inquire what to look for in the patient and how to proceed. LPN reported they inadvertently administered Kinrix (prefilled syringe) to a 1 year 3 month old patient. LPN declined follow-up from safety. Did not consent to follow-up.
Aching in arm, unable to move arm (right arm only). Also sweating and fainting about 12 hrs after vaccine.